A.R. Bradley
Papers
3
Total Citations
16
H-Index
3
About
A.R. Bradley is an emerging researcher at the forefront of fragment-based drug discovery and high-throughput structural biology, with a particular focus on bridging the critical gap between fragment screening and potent lead compound development. Bradley's most significant contribution is the development of Binding-Site Purification of Actives (B-SPA), an innovative methodology that combines multi-step array synthesis with high-throughput (HT) crystallography to dramatically accelerate fragment hit progression — historically one of the most challenging bottlenecks in structure-based ligand discovery. This work, appearing across multiple publications between 2023 and 2025, demonstrates how low-cost robotic workflows and crude reaction mixture deconvolution can make large-scale crystallographic data collection both practical and economically viable. By harvesting the rich structural information embedded in crystallographic fragment screens, Bradley's approaches enable researchers to efficiently explore chemical space around fragment hits without the prohibitive costs traditionally associated with such campaigns. With cumulative citations already building across a compact but focused body of work, Bradley represents a researcher making targeted, methodologically driven contributions that stand to meaningfully reshape workflows in early-stage drug discovery and chemical biology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3